Literature DB >> 20616052

Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties.

Kwang-il Lim1, Ryan Klimczak, Julie H Yu, David V Schaffer.   

Abstract

Retroviral vectors offer benefits of efficient delivery and stable gene expression; however, their clinical use raises the concerns of insertional mutagenesis and potential oncogenesis due to genomic integration preferences in transcriptional start sites (TSS). We have shifted the integration preferences of retroviral vectors by generating a library of viral variants with a DNA-binding domain inserted at random positions throughout murine leukemia virus Gag-Pol, then selecting for variants that are viable and exhibit altered integration properties. We found seven permissive zinc finger domain (ZFD) insertion sites throughout Gag-Pol, including within p12, reverse transcriptase, and integrase. Comprehensive genome integration analysis showed that several ZFD insertions yielded retroviral vector variants with shifted integration patterns that did not favor TSS. Furthermore, integration site analysis revealed selective integration for numerous mutants. For example, two retroviral variants with a given ZFD at appropriate positions in Gag-Pol strikingly integrated primarily into four common sites out of 3.1 x 10(9) possible human genome locations (P = 4.6 x 10(-29)). Our findings demonstrate that insertion of DNA-binding motifs into multiple locations in Gag-Pol can make considerable progress toward engineering safer retroviral vectors that integrate into a significantly narrowed pool of sites on human genome and overcome the preference for TSS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20616052      PMCID: PMC2906550          DOI: 10.1073/pnas.1001402107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  One step screening of retroviral producer clones by real time quantitative PCR.

Authors:  G J Towers; D Stockholm; V Labrousse-Najburg; F Carlier; O Danos; J C Pagès
Journal:  J Gene Med       Date:  1999 Sep-Oct       Impact factor: 4.565

Review 2.  Molecular genetics and target site specificity of retroviral integration.

Authors:  M L Holmes-Son; R S Appa; S A Chow
Journal:  Adv Genet       Date:  2001       Impact factor: 1.944

3.  Target integration by a chimeric Sp1 zinc finger domain-Moloney murine leukemia virus integrase in vivo.

Authors:  Wen-Jiun Peng; Chau-Ming Chang; Thy-Hou Lin
Journal:  J Biomed Sci       Date:  2002 Mar-Apr       Impact factor: 8.410

4.  Development of zinc finger domains for recognition of the 5'-ANN-3' family of DNA sequences and their use in the construction of artificial transcription factors.

Authors:  B Dreier; R R Beerli; D J Segal; J D Flippin; C F Barbas
Journal:  J Biol Chem       Date:  2001-05-04       Impact factor: 5.157

5.  HIV-1 integration in the human genome favors active genes and local hotspots.

Authors:  Astrid R W Schröder; Paul Shinn; Huaming Chen; Charles Berry; Joseph R Ecker; Frederic Bushman
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

Review 6.  Genomic strategies to identify mammalian regulatory sequences.

Authors:  L A Pennacchio; E M Rubin
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

7.  Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.

Authors:  Salima Hacein-Bey-Abina; Françoise Le Deist; Frédérique Carlier; Cécile Bouneaud; Christophe Hue; Jean-Pierre De Villartay; Adrian J Thrasher; Nicolas Wulffraat; Ricardo Sorensen; Sophie Dupuis-Girod; Alain Fischer; E Graham Davies; Wietse Kuis; Lilly Leiva; Marina Cavazzana-Calvo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

Review 8.  Occurrence of leukaemia following gene therapy of X-linked SCID.

Authors:  Donald B Kohn; Michel Sadelain; Joseph C Glorioso
Journal:  Nat Rev Cancer       Date:  2003-07       Impact factor: 60.716

9.  Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.

Authors:  Renate König; Yingyao Zhou; Daniel Elleder; Tracy L Diamond; Ghislain M C Bonamy; Jeffrey T Irelan; Chih-Yuan Chiang; Buu P Tu; Paul D De Jesus; Caroline E Lilley; Shannon Seidel; Amanda M Opaluch; Jeremy S Caldwell; Matthew D Weitzman; Kelli L Kuhen; Sourav Bandyopadhyay; Trey Ideker; Anthony P Orth; Loren J Miraglia; Frederic D Bushman; John A Young; Sumit K Chanda
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

10.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

View more
  18 in total

1.  Retroviral infection of hES cells produces random-like integration patterns.

Authors:  Kwang-il Lim
Journal:  Mol Cells       Date:  2012-04-20       Impact factor: 5.034

Review 2.  Genetic therapies for cystic fibrosis lung disease.

Authors:  Patrick L Sinn; Reshma M Anthony; Paul B McCray
Journal:  Hum Mol Genet       Date:  2011-03-21       Impact factor: 6.150

3.  Advances in homology directed genetic engineering of human pluripotent and adult stem cells.

Authors:  Kalpith Ramamoorthi; Donald Curtis; Prashanth Asuri
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

4.  An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells.

Authors:  Jae-Hyung Jang; James T Koerber; Jung-Suk Kim; Prashanth Asuri; Tandis Vazin; Melissa Bartel; Albert Keung; Inchan Kwon; Kook In Park; David V Schaffer
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

5.  Synthetic biology advances and applications in the biotechnology industry: a perspective.

Authors:  Leonard Katz; Yvonne Y Chen; Ramon Gonzalez; Todd C Peterson; Huimin Zhao; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2018-06-18       Impact factor: 3.346

Review 6.  From DNA to targeted therapeutics: bringing synthetic biology to the clinic.

Authors:  Yvonne Y Chen; Christina D Smolke
Journal:  Sci Transl Med       Date:  2011-10-26       Impact factor: 17.956

Review 7.  Ex vivo gene therapy for HIV-1 treatment.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Hum Mol Genet       Date:  2011-04-19       Impact factor: 6.150

8.  Evaluating different DNA binding domains to modulate L1 ORF2p-driven site-specific retrotransposition events in human cells.

Authors:  Catherine M Ade; Rebecca S Derbes; Bradley J Wagstaff; Sara B Linker; Travis B White; Dawn Deharo; Victoria P Belancio; Zoltán Ivics; Astrid M Roy-Engel
Journal:  Gene       Date:  2017-11-14       Impact factor: 3.688

9.  The mechanism of retroviral integration from X-ray structures of its key intermediates.

Authors:  Goedele N Maertens; Stephen Hare; Peter Cherepanov
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

10.  Astrocytes regulate adult hippocampal neurogenesis through ephrin-B signaling.

Authors:  Randolph S Ashton; Anthony Conway; Chinmay Pangarkar; Jamie Bergen; Kwang-Il Lim; Priya Shah; Mina Bissell; David V Schaffer
Journal:  Nat Neurosci       Date:  2012-09-16       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.